FGFR2 and syndromic craniosynostosis: Apert syndrome, which was well described by a number of authors earlier [1,2] is a rare congenital anomaly, appearing with a frequency of 1 in 55,000 to 90,909 live births [1,3,4] is one of the five craniosynostosis syndromes caused by allelic mutations of the fibroblast growth-factor receptor 2 (FGFR2) [5].